San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

Regulations
May.18.2022
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1
San Diego Officially Bans Sale of Flavored Tobacco Products Beginning Jan. 1

The San Diego City Council officially passed an ordinance Tuesday to ban the sale of flavored tobacco products — including menthol — in the city, effective Jan. 1, 2023.

 

The move — spearheaded by Councilwoman Marni von Wilpert — follows similar actions in cities such as Imperial Beach, Encinitas and Solana Beach, along with San Diego County for unincorporated areas. It also comes months before a statewide referendum tackling the issue in November.

 

The council passed the first reading of the issue in April. This second vote makes the ordinance — known as the Stop Adolescent Addiction From E-Cigarettes or SAAFE Act — law.

 

“I thank my colleagues for standing with me to stop Big Tobacco from addicting an entire new generation of youth on tobacco products by officially approving the SAAFE Act,” von Wilpert said. 

 

“Flavored tobacco products are intentionally marketed to kids and I am proud that our city is taking action to prevent the sale of these products and protect our youth.”

 

The ordinance does not apply to the sale of shisha, premium cigars or loose-leaf tobacco and unflavored or tobacco-flavored e-cigarettes, as well as FDA-approved cessation devices that will also be exempt from the ban.

 

Councilwoman Jennifer Campbell said in her 40 years practicing medicine, she had seen the impact on children who lived in homes with smokers.

 

“We must stop Big Tobacco from aggressively targeting our children and vulnerable communities,” she said. “The Stop Adolescent Addiction From E-Cigarettes will help protect our communities from the tobacco industry making life-long customers addicted to nicotine.”

 

According to findings presented in April by von Wilpert’s office, in the most recent completed study of the city’s tobacco retailers in 2019, 14.7% of retailers sold to an underage police decoy. In a study to come, she said, those numbers have increased to nearly 30%.

 

Source:TIMESOFSANDIEGO

In opposition to the law at the lengthy public hearing in April were dozens of small business owners, who claimed flavored tobacco made up anywhere from 25% to nearly half of their business. Nearly all of them claimed they were law-abiding business owners who had been commended by the San Diego Police Department for their above-board operations. Several also decried what they called the paternalistic nature of the city council’s new law, saying parents should be in charge of how children were raised, not the government.

Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
The Tobacco and Vapes Bill has entered the report stage in the UK House of Lords, with further examination scheduled to begin on February 24, 2026. The legislation aims to create the first “smoke-free generation” by ensuring that individuals who are 15 years old or younger in 2026 can never legally be sold tobacco.
Regulations
Feb.22
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
The U.S. International Trade Commission (USITC) voted to institute a Section 337 investigation into certain disposable and other closed-system electronic nicotine delivery systems (ENDS) devices and components thereof (Inv. No. 337-TA-1486). The investigation stems from a complaint filed on January 13, 2026 by R.J. Reynolds entities based in Winston-Salem, North Carolina, supplemented on February 3, 2026.
Mar.05 by 2FIRSTS.ai
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
E-cigarette brand Lost Vape has recently listed its open-system DTL device, the ASTARA, on its official website. The company markets the product as “The First 4D Portable Shisha Experience,” highlighting a 360-degree display and audio features. The ASTARA has also appeared on some online sales channels in markets including the UK and Germany.
Feb.03 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11